Elizabeth S. Ginsburg

Elizabeth S. Ginsburg

Auto-generated profile, based on publicly available information

Elizabeth S. Ginsburg

Center for Infertility and Reproductive Surgery, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, Massachusetts

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2012 in Fertility and Sterility
Verified
Journal Article
Closed access
SBSara E. Barton
Sara E. Barton
KCKatharine F. Correia
Katharine F. Correia
SSShirley Shalev
Shirley Shalev
SMStacey A. Missmer
Stacey A. Missmer
LLLisa Soleymani Lehmann
Lisa Soleymani Lehmann
EGElizabeth S. Ginsburg
Elizabeth S. Ginsburg

12 March 2021 in Fertility Research and Practice
Verified
Journal Article
Open access
PDF file
AJAlesia Marie Jung
Alesia Marie Jung
SMStacey A. Missmer
Stacey A. Missmer
DCDaniel W. Cramer
Daniel W. Cramer
EGElizabeth S. Ginsburg
Elizabeth S. Ginsburg
KTKathryn L. Terry
Kathryn L. Terry
LFLeslie V. Farland
Leslie V. Farland
Background: Infertility history may have important implications for clinical practice and scientific discovery. Previous research on the validity of self-reported infertility measurements has been limited in scope and duration (< 5 years). In this study, we validated self-reported infertility history measures 15–23 years after fertility treatment initiation among women who utilized assisted reproductive technology (ART). Methods: Women who received ART treatments from three Boston infertility clinics and who enrolled in a prior study (1994–2003) were re-contacted in 2018 for the AfteR Treatment Follow-up Study (ART-FS). Infertility history was collected from clinical records and two self-report questionnaires (at ART initiation and at ART-FS enrollment). Treatment history included specific details (fresh or frozen embryo transfers, number of cycles) and treatment recall prior to ART initiation. Self-reported infertility diagnoses included polycystic ovary syndrome (PCOS), endometriosis, uterine factor infertility, tubal factor infertility, diminished ovarian reserve/advanced maternal age, male factor infertility, and other/unknown. We compared self-reported measures from 2018 to self-reported and clinical data from prior study initiation, using Cohen’s kappa, sensitivity, specificity, and 95% confidence intervals. Results: Of 2644 women we attempted to recontact, 808 completed the ART-FS, with an average follow-up of 19.6 years (standard deviation: 2.7). Recall of fertility treatment usage had moderate sensitivity (IVF = 0.85, Clomiphene/Gonadotropin = 0.81) but low specificity across different infertility treatment modalities (IVF = 0.63, Clomiphene/Gonadotropin = 0.55). Specific IVF details had low to moderate validity and reliability with clinical records. Reliability of recalled infertility diagnosis was higher when compared to self-report at ART initiation (PCOS K = 0.66, Endometriosis K = 0.76, Tubal K = 0.73) than when compared to clinical records (PCOS K = 0.31, Endometriosis K = 0.48, Tubal K = 0.62) and varied by diagnosis. Conclusions: The ability of women to recall specific IVF treatment details was moderately accurate and recall of self-reported infertility diagnosis varied by diagnosis and measurement method.

17 June 2022 in F&S Reports
Verified
Journal Article
Open access
RHRebecca A. Heidenberg
Rebecca A. Heidenberg
EGElizabeth S. Ginsburg
Elizabeth S. Ginsburg
CGCatherine E. Gordon
Catherine E. Gordon
ALAndrea Lanes
Andrea Lanes
To study the difference in the live birth rates between anovulatory women with hypothalamic hypogonadism (HH) and those with polycystic ovary syndrome (PCOS) and normo-ovulatory women undergoing fresh embryo transfer or frozen embryo transfer (FET). Retrospective cohort study. Academic medical center. Patients with oligoanovulation (HH, n = 47; PCOS, n = 533) and normo-ovulation (tubal factor infertility, n = 399) undergoing in vitro fertilization and intracytoplasmic sperm injection cycles from January 1, 2012, to June 30, 2019. None. Live birth rate. Patients with HH had longer stimulation durations than both patients with PCOS and tubal factor infertility. Patients with HH had fewer oocytes retrieved than patients with PCOS, but their numbers of blastocysts were similar. Patients with HH and tubal factor infertility had similar numbers of oocytes retrieved and blastocysts. In fresh embryo transfer cycles, the live birth rates were similar among patients with HH, PCOS, and tubal factor infertility (37.5% vs. 37.1% vs. 29.3%, respectively). When evaluating FET cycles, patients with HH had lower live birth rates than patients with PCOS (26.5% vs. 46.7%) and tubal factor infertility (42.6%). Live birth rates are similar among patients with HH, PCOS, and normo-ovulation undergoing fresh embryo transfer but are significantly lower in women with HH undergoing FET.

5 January 2026 in Fertility and Sterility
Verified
Journal Article
Closed access
LHLindsay A. Hartup
Lindsay A. Hartup
CGClarisa R. Gracia
Clarisa R. Gracia
CHCassie L. Hobbs
Cassie L. Hobbs
EGElizabeth S. Ginsburg
Elizabeth S. Ginsburg

1 April 2020 in Fertility and Sterility
Verified
Journal Article
Closed access
AGAnna Greer
Anna Greer
EGElizabeth Ginsburg
Elizabeth Ginsburg

30 December 2025 in Fertility and Sterility
Verified
Journal Article
Closed access
EGElizabeth S. Ginsburg
Elizabeth S. Ginsburg